Skip to main content
OpenTrials
Completed

NCT Number: NCT00524355

Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Hanoi, Vietnam

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients from both sexes, aged 18 years or older
  • Patients complaining of symptoms consistent with reflux disease

Exclusion criteria

  • Patients with GI cancer and those where the only reason for the visit is renewing the prescription are excluded

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease

Important dates

Study start
2007
Study completion
2007
First posted
Sep 3, 2007
Registry last updated
Jul 17, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.